Index by Author
RESEARCH ARCHIVE PDF FILES
ON THIS SITE Introduction and Overview |
| QS FAQ's |
| Research Archive Table of Contents |
| Ask the experts on the method |
Contact: Elton Kessel MD Stephen Mumford Dr Ph |
|
The following highlighted publications are linked to Adobe(R) Acrobat(R) PDF files. *NOTE: If you are unfamiliar working with PDF files. Some of the files in the archive are large and will effect download times, there are many files with large illustrations and most were scanned in from hardcopy. Printed copies of the brochures, procedural manual and videos, as well as the articles, reports, and studies that make up the history of this method, are also available to qualified professionals by request to the editor.  R. Abdullah (Asian-Pacific Resource & Research Centre for Women, Kuala Lumpur, Malaysia):. Quinacrine family planning method: Letters to the Editor. Lancet 1994; 343:1425-7. American College of Obstetricians and Gynecologists. ACOG technical bulletin: Sterilization. International Journal of Gynecology and Obstetrics: Technical bulletin 1996; Number 222 - April 1996 (Replaces No. 113, February 1988). A. Aggarwal (Deputy Editor, New Delhi, India). Quinacrine acceptance spreads at NAVSFWI meeting. The 11th Indian Conference on Family Welfare and Voluntary Sterilisation and Family Welfare of India: Newsletter Report Oct. 30, 1996; pp. 1-2. T. Agoestina, I. Kusuma (Hasan Sadikin Hospital, Bandung, Indonesia). Clinical evaluation of quinacrine pellets for chemical female sterilization. Advances in Contraception 1992; 8:141-51. American Medical Association, Chicago, IL: Clayton, C.B., ed.. Quinacrine. In: Guide to prescription and over-the-counter drugs; Random House 1988; p 478. B. N. Ames, L. S. Gold (Division of Biochemistry and Molecular Biology, University of California, Berkeley). Chemical carcinogenesis: too many rodent carcinogens. In: Proceedings of the National Academy of Sciences October 1990; 87:7772-6. J.D. Archer (American Medical Association, Chicago, Illinois). The FDA does not approve uses of drugs (editorial). Journal of American Medical Association 1984; 252(8):1054-55. H. Arshat, A. E. Suan, K. S. Kim (National Population and Family Development Board, Kuala Lumpur, Malaysia). Nonsurgical female sterilization with quinacrine pellets: Malaysian experience. Malaysian Journal of Reproductive Health 1987; 5:61-9. N.R. Bairagi (Indian Rural Medical Association, West Bengal, India); B.C. Mullick (Indian Rural Medical Association, Calcutta, India); E. Kessel (Oregon Health Sciences University, Portland, Oregon); S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina. Comparison of the efficacy of intrauterine diclofenac and ibuprofen pellets as adjuvants to quinacrine nonsurgical female sterilization. Advances in Contraception 1995; 11:303-308.. B.M. Baker. The suppression of malaria. In: Internal Medicine in World War II: Vol II: Infectious Diseases: Coates JB, Havens WP, eds., Medical Department, Department of the Army Washington, D.C. 1963; p 465. A. Bashir (Mother and Child Welfare Association, Faisalabad, Pakistan). Quinacrine: nonsurgical female sterilization. Advances in Contraception Delivery Systems 1993; 9:37-42. A. Bashir, M. Mustansar (Allied Hospital, Punjab Medical College, Faisalabad, Pakistan); M. A. Cheema (Population Study Centre, University of Agriculture); S. Akram (Punjab Medical College); R. Naheed (W.M.O. Gulzar Colony MCH Centre, Faisalabad). Quinacrine non surgical female sterilization. The Gynaecologist 1993; 3:129-36. A Bashir (Mother and Child Welfare Association), Faisalabad, Pakistan . Quinacrine Sterilisation: A Community Service. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.16 (Abstract). F. Bauer, Melbourne, Victoria, Australia. Quinacrine hydrochloride drug eruption (tropical lichenoid dermatitis). Its early and late sequelae and its malignant potential: A review. Journal of the American Academy of Dermatology 1981; 4:239-248. R. Begum, S. N. Bhuiyan (Chittagong Medical College, Chittagong). Quinacrine-non surgical tubal occlusion. In: Indian Progress in Family Welfare: Proceedings of IXth Indian Conference on Family Welfare & Voluntary Sterilization, Ahmedabad 13-15th November, 1992; pp. 239-42. G. Benagiano (Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland). Quinacrine family planning method. (Letter) Response to Editorial of April 23, 1994. Lancet 1994; 344:689. G. Benagiano (Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland). Sterilization by Quinacrine. (Letter) (On the 25-27 July 1994 World Health Organization meeting on quinacrine). Lancet 1994; 344:689. A. Benoit, J. Melancon, M-A. Gagnon (INRS-SANTE, Montreal-Gamelin, Quebec, Canada). Chemically induced tubal occlusion in the human female using intrauterine instillation of quinacrine. Contraception 1975; 12:95-101. M. Berer, Editor. The quinacrine controversy one year on. Reproductive Health Matters 1994; 4:99-106. M. Berer (editor, Reproductive Health Matters, London, United Kingdom):. Quinacrine family planning method: Letters to the Editor. Lancet 1994; 343:1425-7. M. Berer, Editor. The quinacrine controversy continues. Reproductive Health Matters, No. 6 November 1995; pp. 42-6. R.V. Bhatt (Medical College and S.S.G. Hospital, Baroda, India); A. Aparicio, L.E. Laufe (International Fertility Research Program, Research Triangle Park, North Carolina); T.H. Parmley, T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland). Quinacrine-induced pathologic changes in the Fallopian tube. Fertility and Sterility 1980; 33:666-7. R. Bhatt, K. M. Jariwala (Department of Obstetrics and Gynaecology, Medical College and S. S. G. Hospital, Baroda, India); P. Bhiwandiwala, L. Laufe (International Fertility Research Program, Research Triangle Park, North Carolina). Chemical female sterilization using quinacrine pellets. In: Proceedings of the Third International Seminar on Maternal and Perinatal Mortality. Pregnancy Termination and Sterilization, New Delhi, October 3-5, 1980: V. Hingorani, R. D. Pandit, V. L. Bhargava, eds. 1980; pp. 370-7313. R. Bhatt (Baroda Medical College and Hospital, India); C.S. Waszak (Family Health International, Research Triangle Park, North Carolina). Four-year follow-up of insertion of quinacrine hydrochloride pellets as a means of nonsurgical female sterilization. Fertility and Sterility 1985; 44:303-6. R. V. Bhatt (Department of Obstetrics and Gynaecology, Baroda Medical College) and B. M. Amin (General Hospital, Baroda, India). Camp laparoscopic sterilization deaths in Gujarat State, India, 1978-1980. Asia-Oceania Journal of Obstetrics and Gynaecology 1991; 17(4):297-301. S. Bhateja (Dr. Sita Bateja Nursing Home, Langford Garden, Bangalore -560025. INDIA), P. Kini (Chip Trust, 3004, 12 'A' Main, HAL II Stage, Bangalore - 560008. INDIA), Rajgopal. K (Dept. of OB/GYN, Kasturba Medical College, Mangalore -575 001. INDIA). Quinacrine Pellet Non-Surgical Female Sterilization. A Two Year Of Review Of Cases In South India. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.58 (Abstract). S. N. Bhuiyan, R. Begum (Department of Obstetrics and Gynecology, Chittagong Medical College, Chittagong, Bangladesh). Quinacrine non-surgical female sterilization in Bangladesh. Contraception 2001; Nov;64(5):281-6. S. Bjorkman; L.O. Elisson; J. Gabrielsson (University of Lund, Malmo, Sweden). Pharmacokinetics of quinacrine after intrapleural instillation in rabbits and man. Journal of Pharmacy and Pharmacology 1989; 160-3. T. Black (MSI, London), Unpublished report. The quinacrine imperative. Marie Stopes International 1995; . D.A. Blake, N.H. Dubin, M.C. Diblasi, T.H. Parmley, G. Stetten, T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland).. Teratologic and mutagenic studies with intrauterine quinacrine hydrochloride. In: Female Transcervical Sterilization, Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 71. C.S. Carignan, D. Rogow, A.E. Pollack (Association for Voluntary Surgical Contraception (AVSC), New York, New York). The Quinacrine Method of Nonsurgical Sterilization: Report of an Experts' Meeting. Advances in Contraception July 1994; AVSC Working Paper No. 6. H. Chandra, B. Malaviya (Central Drug Research Institute, Lucknow, India. Toxic effects of quinacrine hydrochloride in rhesus monkeys. Contraception 1981; 24:269-74. T.T.T. Chien, D.T. Hieu (The Ministry of Health, Hanoi, Vietnam); T.M. King, C. Waszak (Family Health International, Research Triangle Park, North Carolina). A retrospective study of quinacrine sterilization in Vietnam. Report prepared by Family Health International for presentation at the Quinacrine Sterilization Dissemination Meeting In Hanoi, Vietnam February 1995; . T. R. Choudhury. Frittering of utopian WHO. Indian Medical Tribune, New Delhi 1992; . I.R. Choudhury, New Delhi. WHO lacks transparency: members cautious . Indian Medical Tribune February 15, 1995; . J. Ciak; F.E. Hahn (Walter Reed Army Institute of Research, Washington, DC). Quinacrine (Atabrine): mode of action [bactericidal]. Science 1967; 156:655-56. E.B. Conant (Canisius College, Buffalo, New York). Quinacrine: of medicine, politics and vested interests -- where is the woman in the equation?. Speak Out Magazine of the PRO-CHOICE NETWORK OF WESTERN NEW YORK 1995; Summer. CTU Staff article. Quinacrine pellets have potenial for simple, low-cost female sterilizations . Contraceptive Technology Update. (A monthly newsletter) April 1994; . CTU Staff article. Large quinacrine study comes under fire from family planners . Contraceptive Technology Update. (A monthly newsletter) April 1994; . CTU Staff article. Will American women want Quinacrine?. Contraceptive Technology Update. (A monthly newsletter) April 1994; . CTU Staff article. Quinacrine controversy separates rich and poor nations . Contraceptive Technology Update (a monthly newsletter) August, 1994; . A. Dabancens, A. Guerrero (Department of Experimental Medicine, Faculty of Medicine, Universidad de Chile, Santiago), J. Zipper (Department of Physiology and Biophysics, Faculty of Medicine, Universidad de Chile, Santiago). Quinacrine and copper, compounds with anticonceptive and antineoplastic activity. Contraception September 1994; 50:243-51. A. Dabancens (Cytopathology and Cancer Control Service, Faculty of Medicine, University of Chile); D. C. Sokal (Family Health International, Research Triangle Park, North Carolina); M. Pruyas, M. R. Rivera, J. Zipper (Sótero del Rio Hospital, Area Sur Oriente, Santiago, Chile). Prevalence and standardized incidence rates of preclinical cervical pathology among 1061 women sterilized with transcervical quinacrine hydrochloride pellets. Fertility and Sterility 1995; 64:444-446. R. Dasgupta (and G. S. Mudur, investigative reporter). Multiply and perish. Insight, Calcutta Sunday, January 19, 1997; . O.W. Davidson, C. Wilkins (University of Miami Medical School, Miami, Florida). Chemically induced tubal occlusion in the human female following a single instillation of quinacrine. Contraception 1973; 7:333-9. O.W. Davidson (School of Medicine, University of Miami, Miami, Florida). In: Advances in Female Sterilization: Sciarra JJ, Droegemueller W, Speidel JJ, eds.. Quinacrine-induced tubal occlusion. New York: Harper and Row 1976; pp. 200-7. F. Destefano, J.R. Greenspan, R.C. Dicker, H.B. Peterson, L.T. Strauss, G.L. Rubin (U.S. Department of Health and Human Services, Atlanta, Georgia). Complications of interval laparoscopic tubal sterilization. Obstetrics and Gynecology 1983; 61:153-158. J. M. Diconsiglio, Editor. Risks and rewards: family planners weigh quinacrine. Family Planning World 1994; January/February, pp. 19-20. N.H. Dubin, D.A. Blake, M.C. DiBlasi, T.H. Parmley, T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland). Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys. Fertility and Sterility 1982; 38:735-40. N.H. Dubin, J.D. Strandberg, C.F. Craft, T.H. Parmley, D.A. Blake, T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland). Effect of intrauterine and intravascular quinacrine administration on histopathology, blood chemistry, and hematology in cynomolgus monkeys. Fertility and Sterility 1982; 38:741-7. N.H. Dubin, T.H. Parmley, M.C. Diblasi, R.B. Ghodgaonkar, M.T.M. Jiffry, D.A. Blake, T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland).. Pharmacology of quinacrine hydrochloride with emphasis on its use as a tubal occluding agent. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 60. N.H. Dubin, T.H. Parmley, R.B. Ghodgaonkar, B. Pharm, T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland). Comparative effects of intrauterine instillation of analogues of quinacrine and tetracycline on uterine morphology in the rat. Contraception 1984; 29:553-59. R.L. Dunn, D.R. Cowsar (Southern Research Institute, Birmingham, Alabama); D.H. Lewis (Stolle Research and Development Corporation, Birmingham, Alabama).. Controlled delivery systems for quinacrine for female sterilization. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 128. Economist Staff article. Sterile arguments. The Economist: Science and Technology March 19, 1994; pp. 99-100. C.A. Eddy, C.J. Pauerstein. Anatomic and physiologic factors affecting the development of transcervical sterilization techniques . In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 7-23. L. Edouard (Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, Canada). Letter to the Editor. Non-surgical female sterilisation. Lancet Oct. 2, 1993; Vol. 342. S. Edwards, editor. Quinacrine sterilization method found effective among women in Vietnam. International Family Planning Perspectives 1993; 19:157-8. A.A. El-kady (Boulak El-Dakrour Hospital, Giza, Egypt); M.M. Mansy (Kasr El-Aini Faculty of Medicine, Cairo University, Egypt); H.S. Nagib (Boulak El-Dakrour Hospital, Giza, Egypt); E. Kessel (Oregon Health Sciences University, Portland, Oregon). Histopathologic changes in the cornual portion of the Fallopian tube following a single transcervical insertion of quinacrine hydrochloride pellets. Advances in Contraception 1991; 7:1-9. A.A. El-kady, H.S. Nagib (Boulak El-Dakrour Hospital, Giza, Egypt); E. Kessel (Oregon Health Sciences University, Portland, Oregon). Efficacy and safety of repeated transcervical quinacrine pellet insertions for female sterilization. Fertility and Sterility 1993; 59:301-4. FDA. CFR: Code of Federal Regulations: The clinical investigation of an off-label use of a drug such as quinacrine that is lawfully marketed in the United States. Food and Drug Administration: Code of Federal Regulation (4-1-96 Edition); 312.1-2 p. 72. M.T. Feuerstein. Family Planning in Vietnam [Lancet Commentary on Hieu, et al paper in same issue]. Lancet 1993; 342:188. FHI Staff article. Family Health International's role in quinacrine female sterilization research. Contraceptive Update May 1994; Vol. 14, p. 27. FHI Staff article. FHI quinacrine studies. Contraceptive Update. September 1995; Vol. 16, p. 27. O. G. Fitzhugh, A. A. Nelson, H. O. Calvery (Division of Pharmacology, Food and Drug Administration, Federal Security Agency, Washington, DC). The chronic toxicity of quinacrine (Atabrine). Journal of Pharmacologic Experimental Therapy 1945; Volume 85, pp. 207-21. T. Godal (Director, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease, Geneva). Fighting the parasites of poverty: public research, private industry, and tropical diseases. Science 1994; 264(June 24):1864-6. F. Godlee, assistant editor. WHO in crisis. British Medical Journal 1994; 309:1424-8. F. Godlee, assistant editor. WHO in retreat: is it losing its influence?. British Medical Journal 1994; 309:1491-5. F. Godlee, assistant editor. The regions -- too much power, too little effect. British Medical Journal 1994; 309:1566-70. F. Godlee, assistant editor. WHO at country level -- a little impact, no strategy. British Medical Journal 1994; 309:1636-9. F. Godlee, assistant editor. WHO fellowships -- what do they achieve?. British Medical Journal 1995; 310:110-2. F. Godlee, assistant editor. WHO's special programmes: undermining from above. British Medical Journal 1995; 310:178-82. F. Godlee, assistant editor. WHO in Europe: does it have a role?. British Medical Journal 1995; 310:389-93. F. Godlee, assistant editor. Interview with the director general. British Medical Journal 1995; 310:583-6. A. Goldsmith (Program for Applied Research on Fertility Regulation (PARFR), Northwestern University Medical School, Chicago, Illinois); L.E. Laufe (The University of Texas, Health Sciences Center at San Antonio, San Antonio, Texas); T.M. King (The Johns Hopkins University School of Medicine, Baltimore, Maryland). Discussion: Research and clinical experience with quinacrine. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 141. L.S. Goodman; A. Gilman. Quinacrine. In: The Pharmacological Basis of Therapeutics. Second Edition. New York, Macmillan 1960; pp 1167-73. A.K.Ghosh and A.Hazra, (Dept. Ob/Gynae, National Medical College, India). Non Surgical Female Sterilization With Quinacrine Vis-A-Vis Laparoscopic In Rural India. A Comparative Evaluation. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.59 (Abstract). R. Guzman-Serani (Austral University of Chile, Valdivia, Chile), A. Bernales, L.P. Cole. Clinical Report: Quinacrine-Fused Pellets . In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 100-04. R. Guzman-Serani, A. Bernales (Universidad Austral, Valdivia, Chile); L.P. Cole (Family Health International, Research Triangle Park, North Carolina). Quinacrine hydrochloride pellets: three-year follow-up on a nonsurgical method of female sterilization. Contraception Delivery Systems 1984; 5:131-5. R. Guzman-Serani (Austral University of Chile, Valdivia, Chile); M. Potts, R.G. Wheeler (Family Health International, Research Triangle Park, North Carolina). Non-surgical tubal occlusion. Advances in Contraception Delivery Systems 1985; 1:146-9. R.P. Handler. Health officer, Town of Altamont, New York, Letter to the Editor. Chlorination alone won't control giardiasis. New York Times June 6, 1994; . R. Heywood (St. George's House, Huntingdon, Cambridge, United Kingdom). Toxicological requirements for sclerosing agents or other chemicals for female sterilization. International Journal of Gynecology and Obstetrics 1995; 51(Suppl):S41-S45. D. T. Hieu et al. (Maternal and Child Health, Family Planning Dept, Ministry of Health, Hanoi, Vietnam). Letters to the Editor. Authors' reply to the Shelton and Edouard Letters. Lancet Oct. 2, 1993; Vol. 342. D.T. Hieu (Ministry of Health, Hanoi); T.T. Tan (Maternal and Child Health/Family Planning Center, Namha Province); D.N. Tan (Myvan Hospital, Haihung Province); P.T. Nguyet (Maternal and Child Health/Family Planning Centre, Thaibinh Province); P. Than (Maternal and Child Health/Family Planning Centre, Nghean Province); D.Q. Vinh (Ministry of Health, Hanoi, Vietnam). 31,781 cases of nonsurgical female sterilization with quinacrine pellets in Vietnam. Lancet 1993; 342:213-7. D. T. Hieu, D. N. Tan (Department of Mother and Child Health and Family Planning, Ministry of Health, Hanoi, Vietnam). Quinacrine nonsurgical female sterilization. Current Science 1994; 67:706-9. D.T. Hieu (Ministry of Health, Hanoi, Vietnam). Quinacrine method of family planning. (Letter). Lancet 1994; 343:1040. DT Hieu (Department of MCH and Family Planning, Ministry of Health, Hanoi, Vietnam). Quinacrine Sterilization: Risk Of Ectopic Pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.17 (Abstract). H. Hoogenboom (Association for Voluntary Surgical Contraception). Quinacrine sterilization: Letter to Editor. Lancet October 22, 1994; 344:1160. F. Humphreys, JM Marks. Mepacrine and pregnancy. British Journal of Dermatology 1988; 118:452. C. Israngkun, S. Phaosavadi (Chulalongkorn University, Bangkok, Thailand); R.S. Neuwirth (St. Luke's Hospital Center, New York); R.M. Richart (Columbia University, New York). Clinical evaluation of quinacrine hydrochloride for sterilization of the human female. Contraception 1976; 14:75-80. Council on Drugs. An Agent for the Palliative Treatment of Neoplastic Effusions: Quinacrine Hydrochloride. Journal of the American Medical Association March 28, 1966; Vol 195, No 13. A.A. Joseph, Fred A. Kincl (Laboratory for Reproduction, Brookdale Hospital Centers, Brooklyn, New York). Toxic and antifertility effects of quinacrine hydrochloride in rats. American Journal of Obstetrics and Gynecology 1974; 119:978-81. X.P. Kang (School of Public Health, Beijing Medical University, China); H.Z. Wan (Renming Hospital, Beijing); P. Wang (The First Affiliated Hospital, Beijing); S.X. Wang (School of Public Health, Beijing Medical University); L.P. Chow (School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland). Effectiveness of phenol-atabrine-paste (PAP) instillation for female sterilization. International Journal of Gynecology and Obstetrics 1990; 33:49-57. E. Kessel, S.D. Mumford (International Fertility Research Program, Research Triangle Park, North Carolina). Potential demand for voluntary female sterilization in the 1980s: the compelling need for a nonsurgical method. Fertility and Sterility 1982; 37:725-33. E. Kessel (International Federation for Family Health, Chapel Hill, North Carolina); J. Zipper (Hospital Sotero del Rio, Puente Alto, Chile); S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina). Quinacrine nonsurgical female sterilization: a reassessment of safety and efficacy. Fertility and Sterility 1985; 44:293-8. E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Prospects for nonsurgical female sterilization. (Editorial). International Journal of Gynecology and Obstetrics 1989; 29:1-4. D. Kessler, Commissioner. Regulation of investigational drugs: unapproved uses of approved drugs - role of Food and Drug Agency (FDA). The New England Journal of Medicine 1989; 320:285-6. E. Kessel (International Federation for Family Health, Chapel Hill, North Carolina); J. Zipper (Hospital Sotero del Rio, Puente Alto, Chile); S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina). Surgical vs. nonsurgical female sterilization. MCI newsletter January 1991; No. 16 pp. 1-2. E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Laparoscopic sterilization: an obsolete procedure?. In: Proceedings of The World Congress of Gynaecological Endoscopy, Bombay, India 2-5 December 1993; pp. 34-6. E. Kessel, MD.. Response to AVSC Technical Statement concerning Quinacrine pellets for nonsurgical female sterilization. Memorandum Nov. 5, 1993; . E. Kessel. (International Federation for Family Health. Leasburg, North Carolina). Cost-effectiveness of interventions to lower maternal mortality: the role of quinacrine pellet nonsurgical female sterilization. Pan African Maternal and Child Health International Conference, Cairo May 25-27, 1994; . E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Quinacrine sterilization revisited. (Commentary) (A critique of the WHO position on the quinacrine method). Lancet 1994; 344-698. E. Kessel. Quinacrine sterilization: Letters to the Editor. Lancet November 19, 1994; 344:1434. E. Kessel, J. Zipper, D. T. Hieu, B. Mullick, S. D. Mumford. Quinacrine pellet method of non-surgical female sterilization. In: Advances in Human Reproduction. Proceedings of the VIIIth World Congress on Human Reproduction and IVth World Conference on Falloppian Tube in Health and Disease, Bali, Indonesia. April 1993, The Parthenon Publishing Group London 1995; pp. 501-512. E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Letters to the Editor. American Journal of Obstetrics and Gynecology December 1996; p. 1675. E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). 100,000 quinacrine sterilizations. Advances in Contraception 1996; 12:69-76. E. Kessel. Interview with Elton Kessel at Agra meeting. Newsletter report of the 11th Indian Conference on Family Welfare and Voluntary Sterilisation and Family Welfare of India, Oct. 30 1996; p. 2. E. Kessel, S. Mumford. Letter to the Editor: Quinacrine Sterilization in the United States?. Fertility and Sterility March 1996; Vol. 65, No. 3 p. 679-80. E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon. 100,000 Quinacrine Sterilizations. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.16 (Abstract). E. Kessel. Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon, USA,. Quinacrine sterilization: an assessment of risks for ectopic pregnancy, birth defects and cancer. . Advances in Contraception 1998; 14:81-90. S. Y. Khan (Times of India News Service). Women are guinea pigs in contraceptive trial. Times of India Sunday, March 16, 1997; . S.Y. Khan. Cheap but deadly contraceptive is on 'trial'. Times of India 1997; March 16. T.M. King, N.H. Dubin, D.A. Blake, T.H. Parmley (The Johns Hopkins University School of Medicine, Baltimore, Maryland).. Quinacrine hydrochloride: future research. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ. eds., Philadelphia, Harper and Row 1983; p 138. T. M. King (President, Family Health International, Research Triangle Park, North Carolina). Quinacrine as a method of female sterilization. Association for Voluntary Surgical Contraception (AVSC) offices in New York City (unpublished) December 2, 1993; 11pp. P. Kini (Chip Trust, 3004, 12 'A' Main, HAL II Stage, Bangalore - 560008. INDIA), S. Bhateja (Dr. Sita Bateja Nursing Home, Langford Garden, Bangalore -560025. INDIA), Rajgopal. K (Dept. of OB/GYN, Kasturba Medical College, Mangalore -575 001. INDIA). Quinacrine Pellet Non-Surgical Female Sterilization: A Non-Governmental Service Initiative In South India. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.58 (Abstract). M. Klitsch, Assoc. Editor (Alan Guttmacher Institute). Sterilization without surgery: Special Report. International Family Planning Perspectives 1982; 8:101-104. S. Kumar. Sterilisation by quinacrine comes under fire in India. Lancet 1997; 349:1460. Lancet Editorial. Death of a Study: WHO, what, and why. Lancet 1994; 343:987. Lancet Editorial. Fortress WHO: breaching the ramparts for health's sake. Lancet 1995, Jan. 28; Vol. 345, pp. 203-4. L.E. Laufe (Duke University Medical Center, Durham, North Carolina); L.P. Cole (International Fertility Research Program, Research Triangle Park, North Carolina). Nonsurgical female sterilization. International Journal of Gynaecology and Obstetrics 1980; 18:333-9. L.E. Laufe (The University of Texas, Health Sciences Center at San Antonio, San Antonio, Texas); R.G. Wheeler (International Fertility Research Program, Research Triangle Park, North Carolina).. Quinacrine IUDs. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia: Harper and Row 1983; p 115. L. E. Laufe (formerly of the University of Texas Health Science Center at San Antonio, retired), D. C. Sokal, L. P. Cole (Family Health International, Research Triangle Park, North Carolina), D. Shoupe (Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles), R. S. Schenken (Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio, Texas). Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets. Contraception 1996; 54:181-6. Jack Lippes, M.D. (Department of Obstetrics and Gynecology, Children's Hospital, State Uninversty of New York at Buffalo). What is the future for quinacrine sterilization? Letter to the Editor and Reply of the Author. Fertility and Sterility 2001; 75:1244-45.. P.H. Long.. Treatment of Malaria. In: Internal Medicine in World War II: Vol II: Infectious Diseases: Coates JB, Havens WP, eds., Washington, D.C. Medical Department, Department of the Army 1963; p 493. B. Malaviya, H. Chandra, A.B. Kar (Central Drug Research Institute, Lucknow, India). Chemical occlusion of monkey oviducts with quinacrine: antagonism and reversal with estrogen. Contraception 1975; 12:31-6. Staff article. Post-Congress symposium on nonsurgical female sterilization, Bandung, September 15, 1991. MCI newsletter January 1992; No. 19 p. 2. S. Mehtaji (Grant Medical College and Cama and Albless Hospital, Bombay, India); K. Jadwani, V. Goyal (Institute of Research and Reproduction, Bombay, India).. Chemical sterilization with quinacrine. In: Fourth transaction of scientific papers at the India FRP Contributors' Conference held at the West End Hotel, Bombay, February 24, 1977 Pachauri S, ed., Calcutta, India Fertility Research Programme September 1977; p 167-70. R.N. Merchant (B.Y.L. Nair Hospital and T.N. Medical College, Bombay, India); V.M. Doctor (Breach Candy Hospital, Bombay, India); S.S. Thaku (B.Y.L. Nair Hospital and T.N. Medical College, Bombay, India); M. Sinha (Breach Candy Hospital, Bombay, India); C.L. Jhaveri (Indian Fertility Research Program, Bombay, India); E. Kessel (International Federation for Family Health, Chapel Hill, North Carolina); S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina). Clinico-pathological study of Fallopian tubes after transcervical insertion of quinacrine hydrochloride pellets. Advances in Contraception 1986; 2:79-90. R. H. Merchant (Obstetrics and Gynecology, B.Y.L. Nair Hospital, Bombay, India); S. R. Prabhu (Department of Pathology, T.N. Medical College, Bombay, India); E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Clinicopathologic study of Fallopian tube closure after single transcervical insertion of quinacrine pellets. International Journal of Fertility 1995; 40:47-54. H. Most.. Clinical trials of antimalarial drugs. In: Internal Medicine in World War II: Volume II: Infectious Diseases: Coates JB, Havens WP, eds., Washington, D.C. Medical Department, Department of the Army 1963; p 525. B. Mullick (Indian Rural Medical Association, Calcutta, India); S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina); E. Kessel (Oregon Health Sciences University, Portland, Oregon). Studies of quinacrine and of tetracycline for nonsurgical female sterilization. Advances in Contraception 1987; 3:245-54. B.C. Mullick (Indian Rural Medical Association, Calcutta, India); E. Kessel (Oregon Health Sciences University, Portland, Oregon); S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina. A potential single insertion protocol for quinacrine pellet non-surgical female sterilization. Advances in Contraception 1995; 11:239-244. B C Mullick, N R Bairagi (Indian Rural Medical Association, Calcutta, India). Quinacrine Sterilization: Medroxyprogesterone As Adjuvant. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.17 (Abstract). S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina); E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Sterilization needs in the 1990s: the case for quinacrine nonsurgical female sterilization. American Journal of Obstetrics and Gynecology 1992; 167:1203-7. S. Mumford. Quinacrine sterilization: Letters to the Editor. Lancet November 19, 1994; 344:1434. Fakhar-un-Nisa (King Edward Medical College and Lady Wellingdon Hospital, Lahore, Pakistan).. An early experience with nonsurgical female sterilization. In: Maternal and Child Care in Developing Countries: Kessel E, Awan AK, eds., Thun, Switzerland, Ott Publishers 1989; p 273. B.M.Ogilvie, I.G.Scott. The Wellcome Trust population initiative. Human Reproduction, 12 National Supplement, The British Journal of Fertility and Sterility 1997; 2(2). pp. 95-98. T.H. Parmley, N.H. Dubin, J. Strandberg (The Johns Hopkins University School of Medicine, Baltimore, Maryland); L.E. Laufe (The University of Texas, Health Sciences Center at San Antonio, Texas).. Histologic changes following intrauterine administration of quinacrine hydrochloride. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 89. E. Patek (Karolinska Institute, Huddinge University Hospital, Sweden). Sterilant action of quinacrine [How does it produce infertility in women?]. Fertility and Sterility 1977; 28:692. E. Patek. (Department of Obstetrics and Gynecology, Karolinska Institutet, Huddinge University Hospital, Huddinge, Sweden). Quinacrine hydrochloride: Review and mode of action of an antimalarial, used as an occlusive agent for transvaginal human sterilization. Acta Obstetricia et Gynecologia Scandinavica (Copenhagen) 1979; 58:561-4. PDR. Detailed description of Atabrine (quinacrine). Physicians' Desk Reference 1993; . H.B. Peterson, I. Lubell, F. DeStefano, H.W. Ory (Family Planning Evaluation Division, Centers for Disease Control, Atlanta, Georgia, and The Association for Voluntary Sterilization, Inc., New York, NY, USA). The safty and efficacy of tubal sterilization: an international overview. International Journal of Gynaecology and Obstetrics 1983; 21:139-144. H. B. Peterson, Z. Xia, J. M. Hughes, L. S. Wilcox, L. R. Tylor, J. Trussell. HREF="archive/pete96.pdf">The risk of pregnancy after tubal sterilization: Findings from the U.S. Collaborative Review of Sterilization. American Journal of Obstetrics and Gynecology April 1996; 174:1161-70. H. B. Peterson, Z. Xia, J. M. Hughes, L. S. Wilcox, L. R. Tylor, J. Trussell. The risk of ectopic pregnancy after tubal sterilization. The New England Journal of Medicine March 13, 1997; Vol. 336 Number 11: 762-67. C. Pies (Department of Health science, San José State University, San José, California); M. Potts, B. Young (School of Public Health, University of California at Berkeley). Quinacrine pellets: an examination of nonsurgical sterilization. International Family Planning Perspectives 1994; 20:137-141. A. E. Pollack, C. S. Carignan (Association for Voluntary Surgical Contraception). The use of quinacrine pellets for non-surgical female sterilization. Reproductive Health Matters 1993; 2:119-22. A.E. Pollack, C.S. Carignan (Association for Voluntary Surgical Contraception). Contraception: a technical statement on quinacrine pellets for nonsurgical female sterilization. Advances in Contraception 1994; 10:43-50. Potts M, Benagiano G.. Quinacrine sterilization: a middle road. Contraception 2001; Nov;64(5):275-6. Institute for Development Training. Quinacrine sterilization: non-surgical permanent birth control for women. Questions and answers for family planning clients. Brochure 1995; . Institute for Development Training. Quinacrine sterilization: non-surgical permanent birth control for women. Questions and answers for family planning providers. Brochure 1995; . A. Raj, S. Chakravarty (R.G. Kar Medical College Hospital, Bombay, India).. Permanent female sterilization by chemical method-transcervical insertion of quinacrine. In: Proceedings of the Third International Seminar on Maternal and Perinatal Mortality, Pregnancy Termination and Sterilization: Hingorani V, Pandit RD, Bhargava VL, eds., New Delhi, India 3rd to 5th October 1980. Bombay, India 1981; 476-80. L. Randic M.D. (Department of Obstetrics and Gynecology, University Hospital of Rijeka, Rijeka, Croatia). Nonsurgical female sterilization: comparison of intrauterine application of quinacrine alone or in combination with ibuprofen. Fertility and Sterility 2001; 75:830-31. L. Randic (University of Rijeka, Rijeka, Croatia). Non-surgical female sterilization with quinacrine pellets [Abstract only]. Program Book of Abstracts. Second Congress of the European Society of Contraception. Athens, Greece. 6-9 May 1992; p 74. R.M. Richart (Columbia University College of Physicians and Surgeons, New York, New York). Female sterilization using pharmacologically active agents. In: Research Frontiers in Fertility Regulation: Zatuchni GI, Labbok M, Sciarra JJ, eds., Hagerstown, Harper and Row 1980; p. 262. R. M. Richart.. Sterilization using chemical agents. In: New Trends in Female Sterilization: D. A. F. van Lith, L. G. Keith, E. V. van Hall eds., Chicago 1980; Chap. 14, pp. 150-53. R.M. Richart (Columbia University College of Physicians and Surgeons and The Sloane Hospital for Women New York, New York). Female sterilization using chemical agents. Research Frontiers in Fertility Regulation 1981; 1:1-12. R.M. Richart (Columbia-Presbyterian Medical Center, New York, New York). The use of chemical agents in female sterilization. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 24. A. Rosca, I.V. Surcel (Clinica Obstetrica-Ginecologie 1, UMF Cluj-Napoca); S. Toader (Laboratoral Central Experimental UMF, Cluj-Napoca); O. Rotaru (Facultatea de Medicina Veterinara, Cluj-Napoca). Non-surgical female sterilization using Mepacrine (quinacrine). Obstetrica si Ginecologia. UNFPA 1996; XI(VI):221-4. S.E. Sahwi, M. Kamel, N. Haiba, M. Osman (Alexandria University, Egypt). Hysteroscopic and hysterosalpingographic study after intrauterine insertion of quinacrine pellets for nonsurgical sterilization. Advances in Contraception Delivery Systems 1992; 8:151-9. A. R. Sarin (Department of Obstetrics and Gynecology, Government Medical College, Patiala 147001, India) . Quinacrine Sterilizations: Experience Among High Risk Women. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.16 (Abstract). AR Sarin, A Mohindroo, P Chandra, SS Gill.. Histologic changes in the fallopian tubes after lower dose of transcervical quinacrine insertion. Fertility and Sterility 1998; 70:Suppl. 1 (abstract p-121)S164. A. R. Sarin (Department of Obstetrics and Gynecology, Government Medical College, and Aastha Medical Center, Patiala, India.). Quinacrine sterilization: experience among women at high risk for surgery. Adv Contracept 1999; 15(3):175-8. J.J. Sciarra, moderator. Discussion: Feasibility and acceptability of transcervical sterilization . In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 56-59. L. Shallat. Business as usual for quinacrine sterilization in Chile. Reproductive Health Matters Nov. 1995; No. 6: pp. 144-6. J.A. Shannon, D.P. Earle, JR., B.B. Brodie, J.V. Taggart, R.W. Berliner. The pharmacological basis for the rational use of atabrine in the treatment of malaria. Journal of Pharmacological Experimental Therapy 1944; Vol. 81:307-30. J. D. Shelton (Office of Population, US Agency for International Development, Washington, DC).. Non-surgical female sterilisation, Letter to the Editor . Lancet Oct. 2, 1993; Vol. 342. S.D. Mumford (Center for Research on Population and Security, Research Triangle Park, North Carolina). Vatican control of world health organization population policy: an interview with Milton P. Siegel. The Humanist 1993; 53:21-25. S. Sirohi (Washington, DC correspondent of Insight.). The drug peddlers -- the quick fix method. Insight, Calcutta Sunday, January 19, 1997; . L. Sivin (Population Council, Center for Boimedical Research). Non-surgical female sterilisation, Letter to the Editor . Lancet Oct. 2, 1993; Vol. 342. D. Sokal, D. T. Hieu, D. H. Weiner, D. Q. Vinh, T. Huu Vach, R. Hanenberg (Family Health International, Research Triangle Park, NC 27709, USA). Long-term follow-up after quinacrine sterilization in Vietnam. Part I: interim efficacy analysis. Fertil Steril 2000; Dec;74(6):1084-91. D. Sokal, D. T. Hieu, D. H. Weiner, D. Q. Vinh, T. Huu Vach, R. Hanenberg (Family Health International, Research Triangle Park, NC 27709, USA). Long-term follow-up after quinacrine sterilization in Vietnam. Part II: interim safety analysis. Fertil Steril 2000; Dec;74(6):1092-101. D.C. Sokal, A. Dabancens, R. Guzman-Serani, J. Zipper (Family Health International, Research Triangle Park, North Carolina 27709, USA). Cancer risk among women sterilized with transcervical quinacrine in Chile: an update through 1996. Fertil Steril Jul;74(1):169-71 2000; Jul;74(1):169-71. D. O. Sokal, R. Hanenberg (Family Health International, Research Triangle Park, North Carolina):. Quinacrine family planning method: Letters to the Editor. Lancet 1994; 343:1425-7. D. C. Sokal (Family Health International, Research Triangle Park, North Carolina); J. Zipper (Sótero del Rio Hospital, Santiago, Chile); R. Guzman-Serani (Escuela de Medicina, Universidad Austral de Chile); T. E. Aldrich (Department of Epidemiology, University of North Carolina at Chapel Hill). Cancer risk among women sterilized with transcervical quinacrine hydrochloride pellets, 1977 to 1991. Fertility and Sterility 1995; 64:325-34. D.C. Sokal, J. Zipper, T. King.. Transcervical quinacrine sterilization: clinical experience. International Journal of Gynecology and Obstetrics 1995; 51 Suppl:S59-S69. S. Soroodi-Moghaddam (Family Planning specialist, private practice, Tehran, Iran). Quinacrine pellet method of nonsurgical female sterilization in Iran: preliminary report on a clinical trial. International Family Planning Perspectives 1996; 22:122-123, 127. S. R.. Quinacrine for female sterilization. Current Science (India) 1994; 67:631-2. E. A. Steck (Division of Medicinal Chemistry). The Chemotherapy of Protozoan Diseases. Walter Reed Army Institute of Research 1972; p. 3.121. E. A. Steck (Division of Medicinal Chemistry). The Chemotherapy of Protozoan Diseases. Walter Reed Army Institute of Research 1972; p. 23.162-23.176. A. Suhadi (Department of Obstetrics and Gynecology, Wonosobo Regency Hospital, Central Java Province, Indonesia); A. Soejoenoes (Department of Obstetrics and Gynecology, Dr. Karadi Hospital, Semarang, Indonesia). One year experience using quinacrine pellets for non-surgical female sterilization. Indonesian Journal of Obstetrics and Gynecology 1996; 20:39-43. A. Suhadi, A. Soejoenoes. (Regency Hospital, Wonosobo, and Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia).. Quinacrine pellet nonsurgical female sterilization in Wonosobo, Indonesia. Fertility and Sterility 1997; 67(5):966-8. A. Suhadi (Department of Obstetrics and Gynecology, Regency Hospital, Wonosobo, Central Java, Indonesia), M. Anwar (Department of Obstetrics and Gynecology, Gadjah Mada University Faculty of Medicine, Dr. Sardjito Hospital, Yogyakarta, Indonesia), and A. Soejoenoes (Department of Obstetrics and Gynecology, Diponegoro University Faculty of Medicine, Dr. Kariadi Hospital, Semarang, Indonesia). Four year clinical evaluation of quinacrine pellets for non-surgical female sterilization. Advances in Contraception 1998; 14: 69-77. R. W. Tennant, et al (Cellular and Genetic Toxicology Branch, Toxicology Research and Testing Division, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 1987; 236:933-41. P. S. Thakur (Tripura Branch, Indian Rural Medical Association, Agartala 799 001, Tripura, India). Quinacrine sterilization in Tripura, India. Contraception 2001; Nov;64(5):277-9. A. S. Thurmond (Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland, Oregon); M. K. Jones (Department of Radiology, Kaiser Sunnyside Medical Center, Portland, Oregon); B. Mullick (Indian Rural Medical Association, Calcutta, India); E. Kessel (Department of Public Health and Preventive Medicine, Oregon Health Sciences University, Portland, Oregon). Reversal of sterilization due to application of quinacrine by means of transcervical tubal catheterization. Journal of Vascular and Interventional Radiology 1995; 6:147-9. R.R. Tice (Genetic Toxicology Integrated Laboratory Systems, Research Triangle Park, North Carolina); J. Griffith (Environmental Health and Epidemiology, Inc., Raleigh, North Carolina); L. Recio (Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina). An evaluation of the mutagenicity and carcinogenicity of quinacrine. Unpublished report of Family Health International June 22, 1990; 32pp. Editorial. Contraception crisis. Times of India Tuesday, March 18, 1997; . V. Trujillo (San José Hospital, Santiago, Chile); J. Zipper (Sotero del Rio Hospital, University of Chile, Santiago); B. Viel (Chilean Academy of Medicine); M. Rivera (Sotero del Rio Hospital). Stérilization féminine, non chirurgicale avec l'emploi de quinacrine: efficacité de deux insertions de pellets de quinacrine [Nonsurgical female sterilization using quinacrine: efficacy of two insertions of quinacrine pellets]. Gynecology and Obstetrics 1993; 88:147-50. United States Pharmacopeia Convention (USP). Quinacrine. United States Pharmacopeia of Drug Information (USP DI) 1997; 17th edition: p. 2489 - 2490. D. J. Wallace (Department of Medicine, Cedars-Mount Siani Medical Center, University of California-Los Angeles). The use of quinacrine (Atabrine) in rheumatic diseases: A reexamination. Seminars in Arthritis and Rheumatism 1989; 18(4):282-97. M. Weld (Chairman of Global Population Concerns, Ottawa, Canada). Out of the public's view: the battle for quinacrine. Humanist in Canada 1996, Autumn; pp. 31-2. R.G. Wheeler (International Fertility Research Program, Research Triangle Park, North Carolina). Delivery systems for applying quinacrine as a tubal closing agent. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia, Harper and Row 1983; p 105. Women's Health Journal Staff article. Quinacrine: tests find genetic damage. New Technologies, Women's Health Journal, Latin American and Caribbean Women's Health Network 3-4/95; p. 24. Women's Health Journal Staff article. In Chile, QS studies continue. New Technologies, Women's Health Journal, Latin American and Caribbean Women's Health Network 3-4/95; . E.W. Wilson (Puketona Road, Paihia, New Zealand). The development of new technologies for female sterilization: conclusions and recommendations for research. International Journal of Gynecology and Obstetrics 1995; 51 Suppl:S71-S74. Winthrop-Breon Laboratories, New York. Atabrine hydrochloride (brand of quinacrine hydrochloride): for chemotherapy of giardiasis, tapeworm and malaria. Package insert from Winthrop-Breon Laboratories 1985; 6 pp. Winthrop-Breon Laboratories. Atabrine dihydrochloride: quinacrine hydrochloride [an expanded discussion of package insert information]. New York Monograph undated; . Y.H. Wu (Xin Hua Hospital, Shanghai Second Medical College, China); P.L. Qian (Institute of Pharmaceutical Industry of Shanghai); S.P. Tien (Xin Hua Hospital, Shanghai Second Medical College).. Nonsurgical procedures for manual instillation of a phenol-Atabrine paste (PAP) for female tubal occlusion. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia: Harper and Row 1983; p 151. L.J.D. Zaneveld (University of Illinois at the Medical Center, Chicago, Illinois); A. Goldsmith (Program for Applied Research on Fertility Regulation, Northwestern University Medical School, Chicago, Illinois).. Evaluation of slow-release quinacrine pellets in the pig. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia: Harper and Row 1983; p 122. L.J.D. Zaneveld (University of Illinois at the Medical Center, Chicago, Illinois); A. Goldsmith (Program for Applied Research on Fertility Regulation, Northwestern University Medical School, Chicago, Illinois). Lack of tubal occlusion by intrauterine quinacrine and tetracycline in the primate. Contraception 1984; 30:161-7. G.I. Zatuchni (Program for Applied Research on Fertility Regulation, Northwestern University Medical School, Chicago, Illinois).. Discussion: Chinese techniques for chemical sterilization. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia: Harper and Row 1983; p 172. J.A. Zipper, M. Medel, R. Prager (Instituto de Fisiologia, Escuela de Medicina, Universidad de Chile, and Hospital Barros Luco, Santiago, Chile). Alterations in fertility induced by unilateral intrauterine instillation of cytotoxic compounds in rats. American Journal of Obstetrics and Gynecology 1968; 101:971-78. J.A. Zipper, E. Stachetti, M. Medel (Hospital Barros Luco-Trudeau and Instituto de Fisiologia, Universidad de Chile, Santiago, Chile). Human fertility control by transvaginal application of quinacrine on the Fallopian tube. Fertility and Sterility 1970; 21:581-9. J. Zipper, S. Insunza (School of Medicine, University of Chile, Santiago, Chile).. Pharmacological agents that potentiate or inhibit the occlusive action of quinacrine in the rabbit tube and rat uterus. In: Female Sterilization: Prognosis for Simplified Outpatient Procedures. (Proceedings of a workshop held at Airlie, Virginia, December 2-3, 1971): Duncan CW, Falb RD, Speidel JJ, eds., New York: Academic Press 1972; p 151-8. J. Zipper, M. Medel, E. Stachetti, L. Pastene, M. Rivera, R. Prager.. Chemical agents for transvaginal sterilization. In: Human Sterilization. Proceedings of the conference, Cherry Hill, New Jersey, October 28-31, 1969: Richart RM, Prager DJ, eds., Springfield, Illinois: Charles C. Thomas 1972; p 339-352. J.A. Zipper, R. Prager, M. Medel (University of Chile, Santiago, Chile). Biologic changes induced by unilateral intrauterine instillation of quinacrine in the rat and their reversal by either estradiol or progesterone. Fertility and Sterility 1973; 24:48-53. J. Zipper, E. Stacchetti, M. Medel (University of Chile, Santiago, Chile). Transvaginal chemical sterilization: clinical use of quinacrine plus potentiating adjuvants. Contraception 1975; 12:11-21. J. Zipper, M. Medel (School of Medicine, University of Chile, Santiago; Sotero del Rio Hospital, Puente Alto); A. Goldsmith, D. Edelman (International Fertility Research Program, Research Triangle Park, North Carolina); L. Pastene, M. Rivera (School of Medicine, University of Chile, Santiago; Sotero del Rio Hospital, Puente Alto). The clinical efficacy of the repeated transcervical instillation of quinacrine for female sterilization. International Journal of Gynaecology and Obstetrics 1976; 14:499-502. J. Zipper (University of Chile, Santiago; Sotero del Rio Hospital, Puente Alto, Chile); L.P. Cole, A. Goldsmith, R. Wheeler (International Fertility Research Program, Research Triangle Park, North Carolina); M. Rivera (Hospital Sotero del Rio). Quinacrine hydrochloride pellets: preliminary data on a nonsurgical method of female sterilization. International Journal of Gynaecology and Obstetrics 1980; 18:275-9. J. Zipper (Hospital Sotero del Rio, Santiago, Chile); D. Edelman, L.P. Cole (International Fertility Research Program, Research Triangle Park, North Carolina); M. Rivera (Hospital Sotero del Rio).. Overview of clinical trials with quinacrine. In: Female Transcervical Sterilization: Zatuchni GI, Shelton JD, Goldsmith A, Sciarra JJ, eds., Philadelphia: Harper and Row 1983; p 172. J. Zipper, M. Rivera (Hospital Sotero del Rio, Santiago, Chile); L.P. Cole, E. Brown (Family Health International, Research Triangle Park, North Carolina); R.G. Wheeler (Wheeler Consulting, Product Design and Development, Greenbank, Washington). Efficacy of two insertions of 100-minute releasing quinacrine hydrochloride pellets for nonsurgical female sterilization. Advances in Contraception 1987; 3:255-61. J. Zipper, M. Rivera, A. Dabancens (Sotero del Rio Hospital, University of Chile, Santiago). Non-surgical female sterilization. Review of question: experimental basis, pharmacology, toxicology, efficacy. Rev fr Gynecol Obstet 1993; 88:185-90. J. Zipper-Abragan (Department of Physiology and Biophysics, University of Chile, Santiago); A. Dabancens, A. Guerrero (Department of Experimental Medicine, University of Chile, Santiago); V. Trujillo (San José Hospital, Santiago). Quinacrine revised. Human Reproduction Update 1995; 1:53-72. J. Zipper (Department of Physiology and Biophysics, Faculty of Medicine, University of Chile and Sotero del Rio Hospital, Santiago, Chile); A. Dabancens, A. Guerrero (Department of Experimental Medicine, Faculty of Medicine, University of Chile, Santiago, Chile); V. Trujillo (San Jose Hospital, Santiago, Chile). Quinacrine: sclerosing agent of the utero-tubal junction in women, with anticarcinogenic actions in transplanted tumors in mice. International Journal of Gynecology and Obstetrics 1995; 51(Suppl):S47-S55. JA Zipper, A Dabancens, V Trujillo (Department of Physiology and Biophysics, University of Chile, Santiago, Chile). Quinacrine Sterilization: Development Of The Method. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol 76: Sup. 167:4 p.16 (Abstract). |